Chemours

Forecast & Rating9 analysts currently cover Chemours, with about 44.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $18.78, about 30.9% upside from the current price of $14.34. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 29.5% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Chemours are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 19, 2026; for reference only and not investment advice.